Detalles de la búsqueda
1.
Switching from originator infliximab to biosimilar versus continuing on originator in inflammatory bowel disease: results from the observational Project NORTH study.
Scand J Gastroenterol
; 57(12): 1435-1442, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35833832
2.
Positive predictive value of sustained virologic response 4 weeks posttreatment for achieving sustained virologic response 12 weeks posttreatment in patients receiving glecaprevir/pibrentasvir in Phase 2 and 3 clinical trials.
J Viral Hepat
; 28(11): 1635-1642, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34448313
3.
Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infection.
Liver Int
; 40(5): 1032-1041, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31821716
4.
Parthenolide regulates oxidative stress-induced mitophagy and suppresses apoptosis through p53 signaling pathway in C2C12 myoblasts.
J Cell Biochem
; 120(9): 15695-15708, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31144365
5.
Glecaprevir/Pibrentasvir in patients with chronic HCV genotype 3 infection: An integrated phase 2/3 analysis.
J Viral Hepat
; 26(3): 337-349, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30421537
6.
MicroRNA-181c promotes Th17 cell differentiation and mediates experimental autoimmune encephalomyelitis.
Brain Behav Immun
; 70: 305-314, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29545117
7.
miR-142-5p regulates tumor cell PD-L1 expression and enhances anti-tumor immunity.
Biochem Biophys Res Commun
; 488(2): 425-431, 2017 06 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-28511795
8.
Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively.
J Transl Med
; 14: 45, 2016 Feb 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-26861623
9.
Safety and efficacy of everolimus-eluting stents versus paclitaxel-eluting stents in a diabetic population.
Catheter Cardiovasc Interv
; 81(5): 759-65, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22488756
10.
Outcomes of concomitant percutaneous coronary intervention and balloon aortic valvuloplasty.
Catheter Cardiovasc Interv
; 82(7): E835-41, 2013 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21735514
11.
The independent value of a direct stenting strategy on early and late clinical outcomes in patients undergoing elective percutaneous coronary intervention.
Catheter Cardiovasc Interv
; 81(6): 949-56, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22888029
12.
Bivalirudin versus unfractionated heparin during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome initially treated with fondaparinux: results from an international, multicenter, randomized pilot study (SWITCH III).
J Interv Cardiol
; 26(2): 107-13, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23240743
13.
Real-World Data of Adherence and Drug Survival of Biologics in Treatment-Naïve and Treatment-experienced Adult Patients with Rheumatoid Arthritis.
Adv Ther
; 40(10): 4504-4522, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37566157
14.
Incidence and predictors of acute kidney injury after transcatheter aortic valve replacement.
Am Heart J
; 163(6): 1031-6, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22709757
15.
A novel, minimally invasive access technique versus standard 18-gauge needle set for femoral access.
Catheter Cardiovasc Interv
; 79(7): 1180-5, 2012 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22334384
16.
Impact of diabetes mellitus on long-term clinical outcomes of patients on chronic hemodialysis after percutaneous coronary intervention.
J Interv Cardiol
; 25(2): 147-55, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22010995
17.
Clinical predictors for failure of percutaneous coronary intervention in ST-elevation myocardial infarction.
J Interv Cardiol
; 25(2): 111-7, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22372924
18.
Utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention for type C lesions.
J Interv Cardiol
; 25(5): 452-9, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22672141
19.
Efficacy of Risankizumab versus Secukinumab in Patients with Moderate-to-Severe Psoriasis: Subgroup Analysis from the IMMerge Study.
Dermatol Ther (Heidelb)
; 12(2): 561-575, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35050485
20.
Anlotinib Induces a T Cell-Inflamed Tumor Microenvironment by Facilitating Vessel Normalization and Enhances the Efficacy of PD-1 Checkpoint Blockade in Neuroblastoma.
Clin Cancer Res
; 28(4): 793-809, 2022 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34844980